DNA Replication Flashcards
(90 cards)
DNA REPLICATION MECHANISM
Semi-conservative
- It produces two copies of the original DNA molecule, each of which contains one of original strand, and one newly synthesized strand.
Components required for synthesis of DNA
- All four dNTPs (deoxynucleoside triphosphate)- bldg blocks of DNA molecule (guanosine, adenosine, thymidine, cytidine)
- DNA template
- DNA polymerase
- Co-factor: Magnesium ions- required for DNA polymerase activity
- RNA primer providing a free 3’ OH group. This primer is attached to the template SS DNA sequence
DNA CHAIN ELONGATION CATALYZED BY
DNA Polymerase
DNA POLYMERASE
DNA synthesis in both eukaryotes and prokaryotes
- Catalyzes the formation of a phosphodiester bond between the 3’ OH group of the deoxyribose in the last nucleotide to the 5’ phosphate of the dNTP precursor ( the incoming deoxynucleotide)
- Deoxynucleoside 5’ triphosphate provides the energy source for the reaction ( cleavage of a nucleoside triphosphate to form a nucleoside monophosphate and Pyrophosphate).
Anti-viral Nucleoside analogs- viral reverse transcriptase inhibitors
- AZT- Azidothymidine (Zidovudine)-deoxythymidine
- Didanosine (ddl)—-deoxyadenosine
- lack the 3’ OH
- Utilized by the viral reverse transcriptase enzyme
- Upon incorporation into the ds DNA chain, termination occurs due to the lack of 3’ OH
Anti-Viral Nucleoside analogues- Viral DNA polymerase inhibitor
Acyclovir——deoxyguanosine
-Only activated in infected cells. Only the infected cells possess the viral kinase
-Causes chain termination d/t lack of 3’ OH
Anti-viral Nucleotide Base analogues
TENOFOVIR- adenosine analog
- competes with its natural nucleotide counterpart, deoxyadenosine 5’- triphosphate for incorporation into newly forming HIV DNA
- Once successfully incorporated, termination of the elongating DNA chain ensues and DNA synthesis is interrupted
Cytosine arabinose (araC)= cytosine nucleoside analogues
- Adenosine Arabinose also acts in a similar fashion.
- AraC has a 3’ OH group to act as an acceptor for further chain elongation. however, the OH group at position 2 prevents polymerase adding the next dNTP due to stereo restraints which results in chain termination.
- Ribose sugar replaced by arabinose
* In cells it is rapidly converted to cytosine arabinose triphosphate- acts as a substrate for several human DNA pols
3’ to 5’ exonuclease activity
*DNA POLYMERASE I-as it synthesizes DNA in the 5’-3’ direction, it proofreads using the 3’-5’ exonuclease activity to remove errors. Note: Pol I uses its 5’-3’ polymerase activity to filll in gaps generated during most types of DNA repair
**only removes a nucleotide if its base is not hydrogen bonded to the template
- BOTH DNA POLYMERASE I AND III have 3’ to 5’ exonuclease activity
5’-3’ exonuclease activity
- DNA polymerase I-also removal of the primer and replacing it with DNA. Substrate must be vase paired.
- DNA polymerase III
Bacterial genomes
- Usually circular
- Contain single ORI
- THETA REPLICATION at distinct sites called origins of replication (ORI)
Eukaryotic genomes/chromosomes
- Many replication origins
- No replication termini
- LINEAR REPLICATION
Bacteriophage (bacterial virus) and plasmids that have a DNA genome utilize
ROLLING CIRCLE REPLICATION
OriC
Origin of replication in E.Coli
- Has a length of 245 no
- contains a tandem array of three nearly identical 13-nucleotide sequences and four 9-nucleotide sequences that act as binding sites for DNA protein
- contains DNA sequences that are A-T rich (weak bonding compared to G-C bonding). Thus the OriC facilitates easier melting and strand separation of the DNA molecule.
Initiation of DNA replication ( prokaryotes)
- Initiator proteins ( DNaA protein)- binds to origins of replication and breaks hydrogen bonds between bases
- DNA helicase(DNaB)- opens helix and binds primase to form primosome.
- Helicase inhibitor (DNaC)-delivers helicase to DNA template
- DNA Primase: an RNA polymerase that synthesizes the RNA primer on the lagging strand to enable DNA polymerase to syntesize DNA strand.
- DNA polymerase I: removes the RNA primer and replace with DNA
- DNA polymerase III: synthesis of leading and lagging strands.Synthesizes the Okazaki fragments
Note: Leading strand synthesis requires one priming event
*Single stranded DNA binding protein (ssb): binds SS DNA in the replication bubble and prevents it from annealing or forming secondary structure
Single-strand binding proteins (SSB) proteins
Binds to SS DNA in the replication fork to prevent reannealing and straightens out the DNA template to facilitate the DNA polymerization process.
RNAseH and FEN-1 protein
Removes the RNA primer in eukaryotes
Helicase (DNaB)
Unwinds DNA in opposite directions away from the origin
DNA LIGASE
- Joins the Okazaki fragments together
- LIGASE generates a phosphodiester bond between adjacent Okazaki fragments. This produces a continuous DNA strand.
- Each Okazaki fragments requires a separate primer
-Ligase utilizes ATP as the energy source for this reaction
CLAMP PROTEIN
Tightly holds the DNA polymerase onto the template for synthesis of long template. There4 it increases expressively
DNA GYRASE ( type II topoisomerase)
- Introduces negative supercoils into the DNA.
- This reduces the positive super coils introduced by the opening of the DNA.
- Also aids in the separation of the DNA during replication and transcription.
CIPROFLOXACIN
- A Quinolone drug that inhibits bacterial DNA gyrase ( Topoisomerase II). This results in a build up of positive supercooling ahead of the replication fork during DNA replication.
- Used in the tx of resp and UTI infections and can also be used to treat anthrax.
- Polymerase-alpha
- synthesizes RNA primer on leading and lagging strand
- low processitivity-falls off after synthesizing a short DNA segment
- No exonuclease activity
- Polymerase- sigma
- main replicative enzyme
- synthesizes DNA from leading and lagging strands
- high processitivity-can syntesize long stretches of DNA.
- 3’-5’ exonuclease proofreading activity.
Eukaryotic DNA polymerase
- CAMPTOTHECIN
- Anti-cancer drug
- Binds to and inhibits topoisomerase I activity. This results in DNA damage.
- ETOPOSIDE
- Another anti-cancer drug
- inhibits the activity of topoisomerase II. It prevents the re-ligation of DNA. This ultimately leads to DNA damage and apoptosis.
Inhibitors of Eukaryotic replication